ClinicalTrials.Veeva

Menu
Celerion | Phoenix Celerion CPU logo

Celerion | Phoenix Celerion CPU

Research site

Site insights

Top conditions

Top treatments

Itraconazole
Selpercatinib
Rifampin
LY3527723
Donepezil
Midazolam
Omeprazole
MGL-3196
Lansoprazole
Vedolizumab

Parent organization

This site is a part of Celerion

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Active trials

11 of 175 total trials

A Clinical Study of Enlicitide and the Effect of Food in Healthy Adult Participants (MK-0616-033)

The goal of the study is to learn what happens to enlicitide decanoate in a healthy person's body over time when taken on an empty stomach or with fo...

Active, not recruiting
Healthy
Drug: Enlicitide

This study investigates the safety, tolerability and dose equivalence of drug IkT-001Pro in healthy volunteers (18 to 55 years old) in comparison to...

Active, not recruiting
CML
Drug: IkT-001Pro
Drug: Imatinib Mesylate

Researchers have designed a study medicine called opevesostat as a new way to treat prostate cancer.The purpose of this study is to learn what happen...

Enrolling
Healthy
Drug: Carbamazepine
Drug: Opevesostat

This study is the first study with TAK-004 conducted in human beings. Participants will receive either TAK-004 or placebo. The main aim of this study...

Enrolling
Healthy Volunteers
Drug: Placebo
Drug: TAK-004

This is an open label, fixed sequence, 1-way crossover drug-drug interaction (DDI) study in healthy participants.

Enrolling
Healthy Volunteer
Drug: Itraconazole (200 mg)
Drug: varegacestat

This is a study to determine the safety of CDX-622 in healthy participants.

Enrolling
Healthy Participants
Drug: Normal Saline
Drug: CDX-622

The purposes of this study are to:* Learn about the safety and tolerability of CK 4021586 after a single dose and multiple doses in healthy subjects....

Enrolling
Healthy Participants
Drug: CK-4021586
Drug: Placebo for CK-4021586

This study is conducted to determine the Bioequivalence of Ruxolitinib XR 55 mg Tablets With Ruxolitinib IR Tablets Administered Orally in Healthy Pa...

Enrolling
Healthy Participants
Drug: Ruxolitinib XR
Drug: Ruxolitinib IR

Researchers have designed a study medicine called bomedemstat (MK-3543) as a new way to treat certain rare blood diseases.The purpose of this study i...

Enrolling
Healthy
Drug: bomedemstat
Drug: carbamazepine

A First-in-Human 2-part, randomized, double-blind, placebo-controlled, single ascending dose, multiple ascending dose, and food effect, investigation...

Not yet enrolling
Healthy Adult Participants
Drug: Placebo
Drug: PORT-77

This study in healthy volunteers will provide a basis for evaluation of TRL345 as a first in human study, specifically, important safety, tolerabilit...

Active, not recruiting
Healthy Volunteers
Drug: TRL345, a human monoclonal antibody

Trial sponsors

Takeda logo
Janssen (J&J Innovative Medicine) logo
Lilly logo
Merck Sharp & Dohme (MSD) logo
Vertex Pharmaceuticals logo
C
Acerta Pharma logo
C
Corcept Therapeutics logo
Madrigal Pharmaceuticals logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems